We determined the effect of mutations generated in HIV-1 LTR on viral gene expression in six mother-infant pairs following vertical transmission. We show that the functional domains critical for LTR function, the promoter (TATAA), enhancers (three SpI and two NFκB sites), the modulatory region (two AP-I sites, two NFAT, one NF-IL6 site, one Ets-1, and one USF-1) and the TAR region were generally conserved among mother-infant pairs, although we observed several patient and pair specific mutations in these important domains. We then determined the promoter activity of our mother-infant LTR sequences by measuring CAT gene expression, which was driven by these LTRs and found that most of these HIV-1 LTRs derived from 6 mother-infant pairs were functional. However, mutations in the important transcription factor binding sites, including TATAA, SpI, NFκB, AP-I, NFAT, NF-IL6, Ets-1, USF-1 and TAR resulted in reduced LTR driven CAT gene expression. Taken together, conservation of functional domains in the LTR during vertical transmission supports the notion that a functional LTR is critical in viral replication and pathogenesis and mutations generated during the course of infection correlated with HIV-1 gene expression.
Introduction
HIV-1 long terminal repeat, or LTR, is a cis-acting sequence that flanks the HIV-1 genome and is necessary for proviral DNA synthesis, integration of proviral DNA into the host genome and transcription of the viral genes and full length genome (AlHarthi et al., 1998; Gaynor, 1992) . The LTR can be divided into three regions: U3, R, and U5 (Pereira et al., 2000) . Within U3 there are three functional regions, the promoter (positions − 78 to − 1) which contains the TATAA box, the enhancer (− 105 to − 79) which is comprised of two NFκB transcription factor binding sites and three GC rich SpI sites (Gaynor, 1992) , and the modulatory region (− 454 to − 104) which contains two AP-I sites, two NFAT sites, one NF-IL6 site, one USF-1 site, and one Ets-1 site. The R (+ 1 to +99) region contains a unique enhancer element termed TAR (+ 1 to + 60), or transactivation response element, which is important for Tat activation, efficient reverse transcription, and efficient packaging of viral genomic RNA (Feng and Holland, 1988; Harrich et al., 2000; Helga-Maria et al., 1999) . While LTR diversity in infected individuals has been examined (Blackard et al., 2000 (Blackard et al., , 2001 , there has been no systematic study performed that correlates mutations generated during vertical transmission with HIV-1 gene expression.
Vertical transmission of HIV-1 accounts for 90% of all HIV-1 infections in children and occurs at a rate of 30% (Ahmad, 2000 (Ahmad, , 2005 (Ahmad, , 2008 Pitt et al., 1997) . Vertical transmission can occur at three stages: prepartum (in utero), intrapartum (during birth), and postpartum (breastfeeding). Several parameters have been identified with HIV-1 vertical transmission, including advanced clinical stage of the mother, low maternal CD4 + lymphocyte count, high viral load, prolonged exposure of the infant to maternal body fluids (Mayaux et al., 1995; Pitt et al., 1997; Sperling et al., 1996) , and a high viral heterogeneity in the mother (Ahmad et al., 1995; Wolinsky et al., 1992) . However, using antiretroviral therapy (ART) during pregnancy can significantly reduce the rate of vertical transmission (Sperling et al., 1996) , but it also selects for the transmission of ART resistant strains (Colgrove et al., 1998) . We and others have shown, by analyzing the env gene, the HIV-1 minor genotypes (Ahmad et al., 1995; Mulder-Kampinga et al., 1995; Wolinsky et al., 1992) with macrophage tropic and non-syncytium-inducing phenotypes (R5 viruses) (Matala et al., 2001; Salvatori and Scarlatti, 2001) were transmitted from mother to infant. In addition, analysis of HIV-1 regulatory (tat and rev) and accessory (vif, vpr, vpu, and nef ) has shown a high conservation of functional domains of these proteins during vertical transmission (Hahn et al., 2003; Husain et al., 2001; Ramakrishnan et al., 2005; Yedavalli et al., 1998a,b; . We have also shown that transmitting mothers' vif and vpr sequences were more heterogeneous and more functional compared with non-transmitting mother's sequences. Furthermore, we have recently shown that there was a low degree of genetic diversity and high conservation of functional motifs in HIV-1 LTR in six mother-infant pairs following vertical transmission (Mehta et al., in press ). Based on this analysis, we evaluated the functional activity of motherinfant LTR driven CAT gene expression to measure the strength of HIV-1 promoter as well as the effect of mutations in LTR on HIV-1 gene expression.
We show that the functional domains in the HIV-1 LTR sequences, including the promoter, enhancers and modulatory regions derived from six mother-infant pairs were conserved and correlated with efficient viral gene expression. Furthermore, we found that mutations generated in the promoter, enhancer and/or modulatory regions of the mother-infant LTR sequences resulted in reduced LTR driven CAT gene expression. These results underscore the importance of the functional domains of HIV-1 LTR in viral gene expression, transmission and pathogenesis.
Results

Mutations in HIV-1 LTR in mother-infant pairs
Multiple independent (6 to 8) polymerase chain reactions (PCRs) were performed on peripheral blood mononuclear cells (PBMC) DNA from six mother-infant pairs, a total of 13 patients including one mother that gave birth to HIV-1 infected twins. Eight to fifteen LTR clones, containing U3, R, and a small portion of U5, were obtained from each patient (a total of 218 clones from all patients), cloned upstream of CAT gene and sequenced. These LTR sequences derived from patients' PBMC DNA represent both replicating and non-replicating viruses. The phylogenetic analysis was done and we found a low degree of viral heterogeneity and estimates of genetic diversity in HIV-1 LTR from six mother-infant pairs' sequences (Mehta et al., in press ). Based on the molecular characterization, we selected 10 clones from each patient and determined the promoter activity of the LTR in the presence of HIV-1 Tat. In addition, 5 clones from each patient were used to determine the basal activity of HIV-1 LTR driven CAT gene expression. The complete LTR sequences of 218 clones from 6 mother-infant pairs can be retrieved from the Genbank (accession numbers DQ848353-DQ848563). In Fig. 1 , we show only the nucleotide alignment of the important transcription factor binding sites of selected mother-infant HIV-1 LTR clones that exhibited mutations in these sites, as aligned with HIV-1 NL4-3. Each mother-infant pair (B to H) is labeled alpha-numerically with clones derived from a mother labeled with M and those derived from an infant with I.
Analysis of functional domains in mother-infant LTR sequences
HIV-1 LTR contains the promoter (TATAA), enhancers (NFκB, Sp1) and other transcription factors binding sites (AP-I, NFAT, NF-IL6, USF-I and Ets-1) and TAR (Gaynor, 1992) . We analyzed and compared each transcription factor binding site of our mother-infant LTR sequences (accession numbers DQ848353-DQ848563) with that of HIV-1 NL4-3 (Mehta et al., in press) and previous mutational analysis studies related to HIV-1 LTR (Gaynor, 1992; Hiebenthal-Millow et al., 2003; Naghavi et al., 1999; Pereira et al., 2000; Reddy and Dasgupta, 1992) . We show those mother-infant LTR clones that exhibited variability compared with HIV-1 NL4-3 in Fig. 1 . In these clones, the TATAA element that is critical for both basal and Tat-induced LTR transcription (Berkhout and Jeang, 1992; Garcia et al., 1989) showed a mutation from T to A at the third nucleotide in pair-G sequences ( Fig. 1) , which may alter the binding site for the TATAA binding protein (TBP) and possibly hindering RNA Pol II initiation of transcription (Hampsey, 1998) . However, this pair has a CATAA box starting two nucleotides upstream of wild type TATAA box, similar to TATAA box of HIV-1 subtype E LTR (Montano et al., 1998; van Opijnen et al., 2004) , which initiates transcription with similar efficiency (van Opijnen et al., 2004) .
Our analysis of the two NFκB binding sites located within the HIV-1 LTR (Sweet et al., 2005) showed that most LTR sequences were conserved for the two NFκB sites (Mehta et al., in press ). However, five infant clones from pair-B (IB2, IB5, IB9, IB14, IB26) showed mutations in both sites; one clone from pair-D (MD14), one clone from pair-E (ME11), one clone from pair-G (IG2), and in pair-H three clones (MH13, IH1-1, IH1-5) showed mutations in the second site (Fig. 1) . It has been reported that mutations of NFκB motifs in HIV-1 LTR-CAT constructs results in marked decreases in gene expression following transfection into lymphoid cells with or without Tat (Nabel and Baltimore, 1987) . Several studies have also shown that when the upstream NFκB site is mutated, gene expression is reduced five-fold and this effect is more profound when the first site was altered (Berkhout and Jeang, 1992; Montano et al., 1998) . We found that the first NFκB site was mostly conserved with the exception of 5 infant clones from pair-B. We also observed in pair-G, all mother clones and some infant clones, contain a 27 base pair insertion 12 base pairs upstream from the second NFκB site (full sequence can be accessed in Genbank).
Our analysis of the three SpI binding sites in HIV-1 LTR (Gaynor, 1992) showed that our mother-infant LTR sequences were generally conserved for the first and second sites, with a majority of changes occurring in the third site (Mehta et al., in press) . While mutations in SpI-III site have little effect on HIV-1 gene expression (Berkhout and Jeang, 1992) , mutations in all three SpI binding sites can markedly decrease Tat-induced activation of the LTR . In pair-B, all mother sequences had a G to A substitution in SpI-II site and four infant-B sequences (IB2, IB5, IB9, IB26) harbored GG to AA mutation in SpI-I site and GG to AA and G to A in SpI-II site (Fig. 1) . These infant-B sequences also had a 6 base pair insertion between SpI-II and SpI-III sites. All sequences from pair-C showed a G to A mutation in SpI-III site and an insertion of G one nucleotide upstream of SpI-III site, whereas some mother's sequences harbored an additional C to T substitution in the SpI-III site (Fig. 1) . Three sequences from pair-D (ID11, ID17, ID22) showed mutations in the first site, where only one sequence from pair-E (IE7) showed a mutation in the second site (Fig. 1) . All sequences from pair-G showed C to T and most of the mother's sequences T to G mutation and all pair-H sequences showed an insertion of an A in SpI-III site.
Transcription factor binding site for AP-I has a consensus sequence of ACTGGT for the first site and CTCAGTC for the second site (Li et al., 1994) and was found to be fairly conserved in our mother-infant LTR sequences. While the first site was mostly conserved in pairs C, D, E, G, and H (Mehta et al., in press ), mutations were generally found in the second site (Fig. 1) . Single mutation in AP-I does not affect LTR transcription as well as substitution of T to G/C (consensus sequence) in both AP-I sites had little effect on both basal levels and PMA activation of the LTR (Li et al., 1994) . We observed that all pair-B sequences had mutations in the first site from AC to TG/TA. In the second site, pairs-B, D, IH1 and IH2 showed a GT to AC mutation, pair-C a GT to CC mutation, and pair-G and MH had a G to A mutation (Fig. 1) .
In the two NFAT transcription factor binding sites, NFAT-I and NFAT-II (Gaynor, 1992) , we found that most of our motherinfant LTR sequences were generally conserved (Mehta et al., in press) , however pair specific substitutions in both sites were also found. Pair-B sequences showed mutations from a T to G and G to A in the first site, A to G and CC to AT/AC in the second site as well as three infant-B (IB2, IB5, IB9) sequences showing mutations in both sites (Fig. 1) . In pair-C, all sequences showed A to G mutation in the first site, AA to GC and C to A in the second site, all mother's sequences T to A mutation and all infant's sequences T to G mutation in the first site ( Fig. 1) . Pair-D, E and G sequences had mutations in both sites, with a T to G and G to A in the first site and in the second site A to G and C to A (pair-D), TA to CG, G to A and C to A (pair-E) and A to G and CC to AT (pair-G) (Fig. 1) . In pair-H sequences, the first site showed a T to G and an A to G mutations, whereas C to A, A to C, and two A to G mutations were found in the second site (Fig. 1) .
NF-IL6 has a binding site in the HIV-1 LTR (Rohr et al., 2003) and increases HIV-1 LTR driven gene expression (Akira and Kishimoto, 1992; Buckner et al., 2002; Ruocco et al., 1996; Tesmer and Bina, 1996) . When we analyzed our mother-infant pairs' LTR sequences, we found that the NF-IL6 binding site was generally conserved, although some pair specific as well as patient specific mutations were observed (Mehta et al., in press ). However, we found that pair-B sequences had A to G and T to C, pair-D sequences A to G and G to A, most pair-E sequences A to G and G to A, mother-G sequences T to C and GT to AC, and infant-G and infant-H1 G to A mutations (Fig. 1) .
The analysis of Ets-1 and USF-1 binding domains in our LTR sequences were generally conserved (Mehta et al., in press ). These two proteins interact cooperatively to activate HIV-1 LTR (Sieweke et al., 1998 ) and the USF-1 binding site also overlaps with NF-IL6 by 4 base pairs (Buckner et al., 2002) . These proteins interact via their DNA binding domains and bind cooperatively to the USF-1 and Ets-1 binding sites in HIV-1 LTR (Sieweke et al., 1998) . We also observed some mutations in both sites, including G to A (infant-B and pair-G) in Ets-1 site (Fig. 1) . Moreover, we found G to A (pair-D, infant-E, pair-G, and infant-H1) in USF-1 site (Fig. 1) . Mutations in these binding domains may affect induction of HIV-1 LTR transcription.
The TAR region is an mRNA that base pairs with itself creating a secondary stem-loop structure which is required for processivity of transcription (Harrich et al., 1994) . Within TAR there are two important regions known as the 3-nucleotide non-base paired bulge and a 6-nucleotide G-rich loop (Harrich et al., 1994) which is required along with the stem for Tat transactivation (Gaynor, 1992) . Tat along with host factors bind to this bulge/loop region (Pumfery et al., 2003; Sune and Garcia-Blanco, 1995) stabilizing the stem-loop structure and allowing transcription to continue. Mutations in these regions will affect secondary stem-loop structure and ultimately hinder the ability of transcription factors to bind. In general, we found that the TAR region from our motherinfant LTR sequences were conserved, especially the bulge and loop motifs (Mehta et al., in press ). However, some mutations were found in the loop, including GG to AA (infant-B) and T to C (infant-G) sequences. In addition, five sequences (MB9, IB2, IB5, IB9, IB26) showed mutations in the loop region (Fig. 1) , and these same clones showed mutations in the stem possibly altering a correct stem-loop formation. Other mutations, including two GG to AA (positions +2 to +3 and +53 to +54) and two G to A (+12 and +44) in four pair-B sequences, G to A (+12) and A to G (+48) in all pair-C sequences, T to C (+14) in all infant-C sequences, A to G (+52) in most of pair-D sequences, A to G (+49) in four infant-E sequences and G to A (+12) and AA to GG (+48 to +49) in all pair-H sequences were observed. These mutations may alter correct TAR formation and HIV-1 transcription.
Characterization of biological activity of LTR from mother-infant pairs
To evaluate the promoter and enhancer activities of our six mother-infant LTR sequences, we selected 10 LTR clones from each mother and infant based on molecular characterization as described previously (Mehta et al., in press ). These LTR sequences were cloned to drive expression of a CAT reporter gene. Since it is difficult to transfect primary T-lymphocytes efficiently, we utilized 293 cells to transfect these LTR-CAT clones along with Tat into 293 as these cells can provide the same levels of transcription factors to mother and infant LTR driven CAT constructs. We also assessed the basal levels of LTR driven transcription from our mother-infant LTR clones (five clones from each patient) by transfecting into 293 cells without Tat. To ensure similar transfection efficiencies, we used a CMV-β-galactosidase expression plasmid as a control for normalization of transfections. We used two LTR-CAT controls: pHIV-CAT (LTR from 3VLTR positions 8890 to 9611) and pHIV-1 NL4-3 LTR-CAT (NL59-CAT) that contains HIV-1 NL4-3 LTR (positions 9030 to 9681, U3, R and some U5). NL59-CAT has the same length of LTR as all mother-infant LTR clones because same primers were used to amplify HIV-1 NL4-3 LTR. Results are expressed as ratios of CAT expression to β-galactosidase expression. In general, we found that most of the selected mother-infant LTR sequences were functional, with variability in HIV-1 gene expression, and this variability correlated with mutations generated in important transcription factor binding sites in the LTR. Fig. 2 shows LTR-CAT expression with and without Tat for pair-B and C sequences. We found that most of the pair-B LTRs were functional with Tat, however several clones (MB6, MB9, MB11, IB2, IB5, IB19) had decreased levels of transcription ( Fig. 2A) . When we assessed the levels of basal transcription, we found these same clones had little or no expression in the absence of Tat (Fig. 2B) . We then examined if mutations found in important transcription binding sites were responsible for the decreased level of LTR-CAT expression. We found that MB6 and MB11 had mutations in SpI-II (Fig. 1) as well as upstream of the AP-I sites (in GenBank), MB9 in SpI-II, USF-1 (Fig. 1) , TAR loop ( Fig. 1) and upstream of the AP-I sites (in GenBank), and IB19 upstream of the AP-I sites. In addition, IB2 and IB5 had four substitutions in the second AP-I site ( Fig. 1) , multiple mutations between the AP-I and NFAT sties (in GenBank), one in Ets-1, two in each NFκB site, three in SpI-II, two in SpI-I, and several in TAR (Fig. 1) . Similarly, pair-C LTR-CAT clones showed comparable CAT expression to the wild type (NL4-3 LTR-CAT) and NL59 with Tat ( Fig. 2C ) and without Tat (Fig. 2D) . However, some clones showed variable levels of CAT expression compared with wild type LTR, pHIV-CAT and NL59, including MC1, MC2 and IC12. We found these clones had mutations: MC1 had mutations downstream of TAR, MC2 upstream of AP-I sites, and IC12 upstream of AP-I sites, and between AP-I and NFAT sites. These mutations are likely altering LTR-CAT expression of these clones.
When we analyzed LTR-CAT expression in pair-D, we found that majority of LTR clones with Tat were expressing comparable levels of CAT to wild type pHIV-CAT and NL59, however MD12, MD14, MD16, ID8, ID12, ID7, ID20 had impaired LTR function (Fig. 3A) . Similarly, basal levels of transcription of MD14, MD16, ID8, ID17, ID20 showed little to no activity (Fig. 3B) . Upon examination of the sequences, we noticed that MD14 had a mutation in NFκB-II site (Fig. 1) , upstream of AP-I sites, between AP-I and NFAT and one in TAR, MD12 between NFAT and NF-IL6, MD16 upstream of AP-I, ID8 upstream of AP-I sites, between SpI-I and TATAA box, and several in U5, ID12 upstream of AP-I, in NF-IL6 and Ets-1, ID17 upstream of AP-I sites, in USF-1, between SpI-II and SpI-I, upstream of TATAA, and downstream of TAR, ID20 upstream of AP-I sites, in AP-I-II, in USF-1, in TAR and in U5, and ID22 upstream of AP-I sites, between AP-I and NFAT, in USF-1, in SpI-I, in TAR, downstream of TAR and in U5. In addition, these infant clones had multiple mutations in TAR. Likewise, the majority of pair-E LTRs showed comparable levels of CAT expression with Tat to that of the controls (HIV-CAT and NL59) (Fig. 3C) . However, we observed that ME6, ME7, ME10, IE4, IE5, IE6, and IE7 had lower levels of CAT expression compared with wild type. In addition, basal levels of transcription of these LTRs without Tat were non-functional, except IE1 and IE9 (Fig. 3D) . Furthermore, we found ME2 had mutations upstream of AP-I sites, between AP-I and NFAT, between NFAT sites, in NF-IL6, in Ets-1, between NFκB and Ets-1, between TATAA and TAR and one in TAR, ME5 between AP-I sites, between AP-I and NFAT, in NF-IL6 and USF-1, ME6 upstream of AP-I sites, between AP-I and NFAT, between NFAT sites, between NFAT and NF-IL6 and between USF-1 and Ets-1, ME10 upstream of AP-I sites, between AP-I and NFAT, and downstream of TAR, and ME11 between USF-1 and Ets-1, in NFκB-II and downstream of TAR. In addition, the infant sequences also contained mutations, including IE1 which had several mutations upstream of AP-I, between AP-I and NFAT, in NFAT-I, between NFAT and NF-IL6, upstream of TATAA, in TAR and in U5, IE4 between AP-I and NFAT, between NFAT and NF-IL6, in TAR and in U5, IE6 upstream of AP-I sites, between NFAT and NF-IL6, between Ets-1 and NFκB-II, and in TAR, IE7 upstream of AP-I, several between AP-I and NFAT, between NFAT and Ets-1, in Ets-1, in SpI-II, upstream of TATAA and in TAR, and IE9 between AP-I and NFAT, between NFAT and NF-IL6, and in TAR. These mutations are most likely altering LTR-CAT expression in these LTR clones.
When we analyzed transcriptional activity of pair-G clones, we found that most clones with the exception of MG4, MG5, MG6, IG9, IG14, and IG16 showed CAT expression with Tat similar or higher to that of the control, HIV-CAT (Fig. 4A) . The basal transcriptional efficiency of these LTRs without Tat showed comparable levels of activity, except MG4, MG6, IG9, IG13, and IG16 that showed lower levels of CAT expression (Fig. 4B) . Upon closer examination of the sequences we found MG4 had a mutation in U5, MG5 upstream of AP-I sites and between NFAT, MG6 and IG9 between NFAT and NF-IL6 with IG9 also having a mutation in U5, IG14 upstream of AP-I sites, and between SpI-I and TATAA, and IG16 upstream of AP-I sites, in NFAT-II, in TAR and in U5. All of the sequences in this pair had a mutation in the TATAA box, TATAA to TAAAA (Fig. 1) , which is similar to the TATAA box of subtype E LTRs (Montano et al., 1998; van Opijnen et al., 2004) . Upon examination of the sequences this pair had a CATAA box instead of a TATAA box. It was also observed that all mother and some infant clones had a 27 base pair insertion 11 base pairs upstream from NFκB-II (the full sequences can be accessed in Genbank). In pair-H sequences, the CAT expression was equal or higher to that of the HIV-CAT and NL59 controls both with (Fig. 4C) and without Tat ( Fig. 4D) . Specifically, MH11, IH1-3, IH1-9, IH1-12, and IH2-5 showed higher levels of CAT as compared to the wild type. However, we found that the basal transcriptional activity of MH13 and IH1-1 were lower than wild type and NL59 and could be due to mutations in the NFκB-II site and between AP-I and NFAT (MH13) and between SpI-I and TATAA (IH1-1) (Fig. 1 ).
Discussion
We have recently shown that the functional domains required for HIV-1 LTR activity were mostly conserved in six motherinfant pairs following vertical transmission (Mehta et al., in press ). Furthermore, the biological characterization of the promoter (TATAA), enhancers (three SP-I sites, two NFκB sites), the modulatory region (two NFAT sites, two AP-I sites, one NF-IL6 site, one Ets-1 site, and one USF-1 site) and the TAR region revealed that these important motifs were generally conserved and functional, although several mutations were found in these sites that correlated with an altered LTR driven CAT gene expression. While the majority of the 146 clones analyzed for biological activity in this study showed a functional LTR, we observed 36 clones that had a gene expression lower than that of the control either with or without Tat (Figs. 2 to 4) contained mutations in either promoter, enhancer or modulatory regions (Fig. 1) . Taken together, these findings suggest that conservation of functional domains in HIV-1 LTR and correlation of mutations generated during vertical transmission with HIV-1 gene expression is consistent with an important role of HIV-1 LTR in viral replication and pathogenesis (Freed, 2001; Garcia et al., 1989; Gaynor, 1992; Reddy and Dasgupta, 1992) .
Of the 36 clones that had decreased gene expression in our study, 10 clones showed mutations within the enhancer region. More specifically IB2, IB5, IB9, and MD14 all showed mutations within the NFκB sites. The three IB clones had mutated GGG sequences of NFκB to AAG in both sites and showed a markedly reduced gene expression with and without Tat induction ( Figs. 2A and 2B) , as also seen with a CTC mutation previously described (Berkhout and Jeang, 1989) . Mutations of the NFκB motifs in HIV-1 LTR-CAT constructs results in marked decreases in gene expression following transfection into lymphoid cells with or without Tat (Nabel and Baltimore, 1987) . Several studies have also shown that when the upstream NFκB site is mutated, gene expression is reduced five-fold and this effect is more profound when the first site was altered (Berkhout and Jeang, 1992; Montano et al., 1998) as we have observed with these three IB clones. Interestingly, the majority of clones from Pair G harbored a 27 base pair insertion 12 bases upstream from the second NFκB site and the BLAST search revealed no similarity to published sequences. Similar insertions known as the most frequent naturally occurring length polymorphisim (MFNLP), which is located just upstream of the NFκB binding sites of variable lengths, has been described before with little effect on transcriptional activity and replication (Hiebenthal-Millow and Kirchhoff, 2002) . However, others studies have shown that MFNLP has a positive effect (Chen et al., 2000; Golub et al., 1990) , a negative effect (Golub et al., 1990; Koken et al., 1992) , or no effect on HIV-1 transcription (Estable et al., 1996) . Within the SpI sites we found that MB6, MB9, MB11, IB2, IB5, IB9, IE7 and IH2-3 had mutations, and IG9 showed a mutation downstream of SpI-I. In vitro transcription studies of mutations in SpI binding sites have shown that elimination of site III did not affect in vitro transcription of the HIV-1 LTR, but mutations in sites I, II, and III resulted in 10-fold decreases in transcription in vitro (Jones et al., 1986) . While mutations in SpI-III site have little effect on HIV-1 gene expression (Berkhout and Jeang, 1992) , mutations in all three SpI binding sites can markedly decrease Tat-induced activation of the LTR . We did not see that any of the clones studied had mutations in all three sites. We also found that all of pair-G sequences (Fig. 1) harbored a mutation of a T to A at the third position of the TATAA element. Mutational analysis of the TATAA box in yeast and human model systems has revealed that the third position is one of the most critical residues and must be a T (Hoopes et al., 1998; Patikoglou et al., 1999; Wobbe and Struhl, 1990) . From this it was expected that pair-G clones should not be functional, however, these sequences possess a CATAA box, also found in HIV-1 subtype E LTR (Montano et al., 1998; van Opijnen et al., 2004) , which is used by approximately 12% of all cellular pol II promoters that initiate transcription as efficiently as a TATAA box (van Opijnen et al., 2004) .
The TAR region (+ 1 to + 60) is critical for HIV-1 Tat-induced HIV-1 transcription and mutations within TAR can significantly reduce LTR driven transcription. Tat along with host factors bind to the bulge/loop region (Pumfery et al., 2003; Sune and GarciaBlanco, 1995) stabilizing the stem-loop structure allowing continued transcription. Mutations in these regions will affect secondary stem-loop structure and ultimately hinder the ability of transcription to continue. We found that 10 clones (MB9, IB2, IB5, IB9, IG9, IG16, MH3, MH12, IH2-3, IH2-7) had mutations in the TAR region with almost half of them showing mutations within the loop region and two clones showing mutations downstream of TAR. It has been reported that mutations in the hexanucleotide loop region of TAR decreases the level of cooperative Cyclin T1 and Tat binding (Helga-Maria et al., 1999) . In addition, mutations in the TAR region may affect secondary stem-loop structure (Das et al., 1997; Feng and Holland, 1988) and decrease Tat and cellular factor binding to the TAR. The three infant-B clones IB2, IB5 and IB9 had mutations within the loop region which have been previously reported ) and little to no CAT expression. Garcia et. al, showed that the mutation of the loop region from CTGGGA to CTAAAA drastically reduced HIV-1 LTR driven gene expression .
Of the 36 clones that had a lower gene expression than the control, 24 sequences had mutations within the modulatory region. More specifically MB6, MB9, MB11, MC2, IC12, MG5, IG14, IG16, MH3 and MH12 had mutations upstream of the AP-I site whereas, IB2, IB5, IB9, and ID20 had mutations within AP-I sites. It has been reported that single mutation in AP-I does not affect LTR transcription and that a substitution of T to G/C in both sites had little effect on basal levels as well as PMA activation of the LTR (Li et al., 1994) . From our motherinfant sequences we also observed IC12 had mutations between AP-I and NFAT sites, but IB2, IB5, IB9, ID12, ME6, ME7, IE5 and IE7 had mutations within the NFAT sites whereas ME2, MG9 and IG9 had mutations downstream of the NFAT sites. Only one clone, ID12 had a mutation within the NF-IL6 site. It has been shown that NF-IL6 can bind to and increase HIV-1 LTR driven gene expression (Akira and Kishimoto, 1992; Buckner et al., 2002; Ruocco et al., 1996; Tesmer and Bina, 1996) , therefore mutations in this site may alter LTR gene expression. USF-1 and Ets-1 interact cooperatively to increase HIV-1 gene expression (Sieweke et al., 1998) and we saw that 5 clones (MB9, ID8, ID17, ID20, and ME5) had mutations within USF-1 and 6 clones (IB2, IB5, IB9, ID12, IE7, and ME2) had mutations within Ets-1.
The 5VLTR does not encode proteins capable of interacting with the immune system. However, Nef overlaps a region of the 3V LTR and immune pressure exerted on these regulatory proteins may indirectly influence LTR diversity (Blackard et al., 2000) . It is also known that the LTR is responsive to cytokines, transcriptional activators, as well as viral proteins. Nucleotide changes within regions responsible for binding these regulators may affect transcriptional fitness. One study has demonstrated that a single point mutation in the LTR abolished responsiveness to one cellular protein while simultaneously increasing responsiveness to another (Verhoef et al., 1999) . These observations suggest that HIV-1 gene regulation by the LTR maybe be linked to transmission (Al-Harthi et al., 1999 , 1998 Hashemi et al., 1999; Montano et al., 1997) . Those LTRs that respond better to host factors will likely be activated at higher levels than those that do not respond, resulting in higher viral gene expression, and ultimately influencing transmission. Better understanding of the mechanisms of vertical transmission needs to be accomplished. Previously, we have characterized many of the viral genes associated with vertical transmission (Hahn et al., 1999 (Hahn et al., , 2003 Husain et al., 2001; Matala et al., 2001; Ramakrishnan et al., 2005; Sundaravaradan et al., 2005; Wellensiek et al., 2006; Yedavalli et al., 1998a,b; , which has allowed researchers to gain a better understanding of molecular mechanisms of vertical transmission. The data presented in this study emphasizes the importance of LTR in viral gene regulation and pathogenesis.
Materials and methods
Patient population and sample collection
This study was approved by the Human Subjects Committee of the University of Arizona, Tucson, Arizona and the Institutional Review Board of the Children's Hospital Medical Center, Cincinnati, Ohio. Written informed consent was obtained from patients participating in this study. Blood samples were collected from mother-infant pairs; the infants' ages at the time of specimen collection were 4.75 months (infant-B), 14 months (infant-C), 28 months (infant-D), 34 months (infant-E) 24 months (infant-G) and 7 months (infant twins-H). The demographic, clinical and laboratory findings for the HIV-1-infected motherinfant pairs are shown in Table 1 . Each mother-infant pair is labeled alpha-numerically with clones derived from the mother labeled with M and those derived from the infant with I.
Isolation of DNA from peripheral blood mononuclear cells
The peripheral blood mononuclear cells (PBMCs) were isolated by a single-step Ficoll-Paque procedure (Pharmacia-LKB, Piscataway, NJ) from the whole blood of HIV-1-positive mothers and their infants. DNA was isolated according to a modified procedure as described previously (Ahmad et al., 1995) . Approximately 10 6 PBMCs were centrifuged at 12,000 rpm for 2 min and the cell pellet was resuspended in 0.5 ml of TNE buffer (0.5 M Tris-HCl [pH 7.5], 0.1 M NaCl, 1 mM EDTA). The suspension was treated with 0.5% sodium dodecyl sulfate (SDS) and proteinase K (10 μg/ml; Boehringer Mannheim, Indianapolis, IN) at 60°C for 3 h, followed by several extractions with phenol and chloroform. The DNA was precipitated with ethanol and dissolved in 50-100 μl of TE buffer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA).
Polymerase chain reaction amplification
A two-step polymerase chain reaction (PCR) amplification, first with outer primers and then with nested or inner primers, was performed to detect the presence of HIV-1 in infected patients PBMCs (Ahmad et al., 1995) . An equal amount of HIV-1 PBMC DNA (approximately 25-50 copies, minimum) was used from each patient as determined by end-point dilution. DNA oligonucleotide outer primers LTR1 (5V CTCAGGTACCTT-TAAGACCAATGACT, sense) and LTR2 (5VTAGAGATTTTC-CACACTGACTAAAA antisense) and inner primers LTR3 (5V GGGGACAAGTTTGTACAAAAAAGCAGGCTAAGGC-AGCTGTAGATCTTAGCCACT, sense) and LTR4 (5VGGGGA-CCACTTTGTACAAGAAAGCTGGGTCTGAGGGATCTCTA GTTACCAGAGT, antisense) were designed according to published HIV-1 sequences of NL4-3. The PCRs were performed according to the procedure of Ahmad et al. (Ahmad et al., 1993) in 25 μl reaction mixtures, each containing 2.5 μl of 10× PCR buffer (100 mM Tris-HCl [pH 8.3], 100 mM KCl, 0.02% Tween 20), 2.5 mM MgCl 2 , 400 μM each of dATP, dCTP, dGTP, and dTTP, 0.2 to 1.0 μM each of outer primers and 2.5 U of TaKaRa LA Taq polymerase enzyme (TaKaRa Biomedicals, Shiga, Japan). The reactions were carried out for 35 cycles, each cycle consisting of 94°C for 30 s, 45°C for 45 s, and 72°C for 3 min. After the first round of PCR, 5 μl of the product was amplified using the corresponding inner primers for 35 cycles using the same parameters. The PCR products were analyzed by electrophoresis on a 1.2% agarose gel.
Construction of an HIV-1 LTR driven CAT gene expression vector
To determine the biological relevance of HIV-1 LTR, we constructed a CAT gene expression vector, which is under the control of HIV-1 LTR cloned from six mother-infant pairs following vertical transmission. To do this, we enzymatically digested CMV-CAT plasmid with HindIII and XbaI in a total volume of 50 μl to remove the CMV promoter such that the CAT gene is left behind. We then made blunt ends, which were dephosphorylated using shrimp alkaline phosphate [SAP (USB)] to prevent the ends from rejoining. This promoterless vector was then used in a ligation reaction with 10-20 ng of GATEWAY Cloning System Reading Frame Cassette C (Invitrogen), and 1 U of T4 DNA ligase in ligase buffer, incubated at 16°C overnight. One microliter of the ligation was transformed into DB3.1 Competent Cells as these cells are not killed by the ccdB gene, which is lethal to any other strain. DNA was isolated from these transformed cells and restriction digests were performed using many different enzymes to ensure the GATEWAY Cloning System Reading Frame Cassette C was inserted in the correct orientation. This is the Destination Vector (DestVC) that was used in the second step of the GATEWAY cloning system (Invitrogen).
Cloning and DNA sequencing
The PCR products amplified by inner primer pair LTR3/ LTR4, which contains U3, R and some U5 regions, were cloned into the GATEWAY cloning system, using DestVC, upstream of CAT gene. Individual bacterial colonies were screened for the presence of recombinants by restriction enzyme analysis of plasmid DNA. The clones with correct sized inserts were selected for large scale DNA preparation, followed by manual sequencing of 8 to 15 clones for each patient. Sequencing was performed using either Sequenase version 2, Thermosequenase cycle sequencing protocol (U.S. Biochemical, Cleveland, Ohio) or ABI PRISM® 3700 DNA automated sequencing system at the University of Arizona Biotechnology center.
Cell lines and DNA transfections
293 cells were cultured in MEM supplemented with 10% FBS (Invitrogen) and 1× penicillin/streptomycin and split as cells reached 75% confluency. Once cells were trypsinized and washed, 293 cells were plated in 6 well plates at 180,000 cells/ well 12-18 h before transfection was performed. On day of transfection, 1.4 μg of LTR-CAT constructs, 0.4 μg Tat DNA, and 0.15 μg of CMV-β-galactosidase (transfection efficiency control DNA) were cotransfected using a lipid based transfection method, Trans-It 293 (Mirus). Briefly, for every microgram of DNA, 2 μl of lipid was used. Lipid was added to 200 μl of Opti-MEM (Invitrogen) and allowed to incubate for 20 min at room temperature. After 20 min, the lipid-Opti-MEM mixture was added dropwise to the DNA. This was then allowed to incubate for 30 min at room temperature. After incubation, fresh media was added to plated cells and 200 μl of lipid-Opti-MEM-DNA mixture was added dropwise to cells. Cells were then lysed with 1× Reporter Lysis Buffer 48 h post-transfection. Lysates were either used for enzymatic assays or frozen and stored at − 80°C for future use.
CAT, β-galactosidase and protein assays
Lysates from transfected 293 cells were then assayed for levels of CAT, β-galactosidase and total cellular protein. CAT was assayed using a CAT-ELISA kit (Roche) per manufacturer's instructions. Briefly, 200 μl of cell lysate was added to the well and allowed to incubate at 37°C for 1 h. The wells were then washed, and an Anti-CAT-DIG antibody was added and incubated for 1 h at 37°C. This was then washed and Anti-DIG-POD was added for another hour at 37°C. After washing, POD substrate was added and allowed to incubate for 15-30 min at room temperature. After color development the absorbance was measured at 480 nm. β-galactosidase levels were determined using a β-Galactosidase Enzyme Assay System with Reporter Lysis Buffer (RLB) (Promega). Briefly, 20 μl of cell lysate was placed into a 96-well plate along with 20 μl of 2× Assay Buffer (200 mM sodium phosphate buffer [pH 7.3], 2 mM MgCl 2 , 100 mM β-mercaptoethanol, and 1.33 mg/ml o-nitrophenol galactopyranoside [ONPG] ) and allowed to incubate at 37°C for 30 min. Absorbance was read immediately at 418 nm in a plate reader. Total cellular protein was assayed using the Protein Assay ESL kit (Roche). Briefly, 20 μl of lysate was pipetted into a 96-well plate. Reagent A was then added (20 μl) and allowed to incubate for 10-15 min at room temperature. Following incubation, 200 μl of Reagent B was then added, and the plate was read immediately at 480 m. Appropriate controls were performed for each assay done.
